Philips combines SPECT camera with flat-panel x-ray
Philips Healthcare showcased at RSNA 2008 a hybrid SPECT/CT that incorporates a flat-panel x-ray system in place of a standard multislice CT. The FDA-cleared scanner, BrightView XCT, which debuted at the Society of Nuclear Medicine meeting in New Orleans, is built around the BrightView SPECT that Philips released commercially last year.
Philips Healthcare showcased at RSNA 2008 a hybrid SPECT/CT that incorporates a flat-panel x-ray system in place of a standard multislice CT. The FDA-cleared scanner, BrightView XCT, which debuted at the Society of Nuclear Medicine meeting in New Orleans, is built around the BrightView SPECT that Philips released commercially last year.
The novel combination is attuned specifically to the needs of specialists in nuclear medicine. The flat panel provides localization and attenuation correction at a lower cost than CT and with less technological complexity, so the system doesn't require special training for technologists, according to the company.
A side benefit is a two-thirds reduction in patient x-ray dose compared with MSCT. The XCT design is compact enough to allow siting in the same 12 x 15-foot room as the SPECT camera alone.
The system is scheduled to begin shipping next year at a price point somewhere between the company's $700,000 six-slice Precedence SPECT/CT and the $350,000 BrightView SPECT gamma camera. Beta testing is expected to begin in Q1 2009.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
